Surgical Science Sweden AB (publ)
SSE:SUS.ST
179.1 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 233.972 | 162.537 | 56.523 | 19.974 | 15.177 | -4.069 | -3.735 | -0.2 | 1.8 | -3.037 |
| Depreciation & Amortization
| 55.613 | 51.585 | 33.517 | 16.976 | 15.188 | 10.124 | 10.644 | 8.8 | 7.1 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -5.653 | -65.609 | -46.687 | -5.841 | 25.575 | 1.399 | 0.121 | 5.6 | -0.4 | 0 |
| Accounts Receivables
| 31.905 | -70.76 | -84.573 | 1.861 | 22.981 | -3.991 | 4.951 | -1.012 | -1.531 | 0 |
| Inventory
| -19.567 | -21.72 | 6.459 | -5.271 | -2.439 | 3.693 | -2.729 | -2.1 | -0.7 | 0 |
| Accounts Payables
| -17.991 | 26.871 | 31.427 | -2.431 | 5.033 | 1.697 | -1.744 | 8.693 | 0 | 0 |
| Other Working Capital
| -17.991 | 26.871 | 31.427 | -2.431 | 5.033 | -2.294 | 2.85 | 7.7 | 0.3 | 0 |
| Other Non Cash Items
| -45.641 | -19.026 | -4.27 | -7.884 | -0.738 | -0.576 | 0.907 | -0.8 | -1 | 3.037 |
| Operating Cash Flow
| 238.291 | 129.487 | 39.083 | 23.225 | 55.202 | 6.878 | 7.937 | 13.4 | 7.5 | 0 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -44.129 | -34.548 | -14.377 | -8.694 | -8.915 | -8.637 | -12.116 | -11.7 | -8.3 | 0 |
| Acquisitions Net
| 0 | 0 | -2,718.237 | 0 | -201.388 | 0 | -5.05 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -33.673 | -25.196 | -10.506 | -8.295 | -8.593 | -7.145 | -5.808 | -11.275 | -0.1 | 0 |
| Investing Cash Flow
| -44.129 | -34.548 | -2,732.614 | -8.694 | -210.303 | -8.637 | -12.116 | -11.7 | -8.4 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -2.042 | -17.093 | -24.169 | -1.321 | -1.086 | -0.336 | -9.425 | 0 | -2.7 | 0 |
| Common Stock Issued
| 19.148 | 0 | 3,039.053 | 9.342 | 200 | 1.576 | 51.163 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | -19.146 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -2.042 | 34.186 | -92.421 | -3.816 | -13.135 | 0.336 | -2.791 | 0 | 2.7 | 0 |
| Financing Cash Flow
| 15.847 | 17.093 | 2,922.463 | 4.205 | 185.779 | 1.912 | 38.947 | 0 | 2.7 | 0 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -9.375 | 5.021 | 0.591 | -0.796 | 0.042 | -0.192 | 0.205 | 0 | 0.1 | 0 |
| Net Change In Cash
| 200.633 | 117.053 | 229.523 | 17.94 | 30.72 | -0.039 | 34.768 | 1.8 | 1.9 | 0 |
| Cash At End Of Period
| 634.366 | 433.733 | 316.68 | 87.157 | 69.217 | 38.497 | 38.536 | 3.8 | 2 | 0 |